Position in CRBU
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,279,078
-$320,476 QoQ
Shares Held
673,200
-33.1% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 137 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 74.50653594771242.ToString("F0")%
Shared 13.096999405822935.ToString("F0")%
None 12.396464646464645.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. CRBU ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in CRBU
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,279,078 | 673,200 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,599,554 | 1,006,010 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,820,021 | 1,210,310 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,647,266 | 1,307,355 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,264,201 | 1,384,669 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,754,480 | 1,732,378 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,026,318 | 2,054,245 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,302,182 | 2,623,283 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,727,800 | 2,087,121 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,739,990 | 1,350,784 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,837,775 | 593,677 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $555,390 | 130,680 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,132,532 | 213,283 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $764,935 | 121,805 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||